TAFINLAR (dabrafenib) capsules is used for the treatment of patients with metastatic melanoma.

TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test. TAFINLAR is indicated, in combination with trametinib, for the treatment of patients with:  unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test.  metastatic non-small cell lung cancer (NSCLC) with BRAF V600E mutation as detected by an FDA-approved test.

TAFINLAR (dabrafenib) capsules suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of TAFINLAR (dabrafenib) capsules brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the TAFINLAR (dabrafenib) capsules cost price in India.

The order for TAFINLAR (dabrafenib) capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dabrafenib (trade name Tafinlar, GSK2118436) is a drug for the treatment of cancers associated with a mutated version of the gene BRAF. Dabrafenib acts as an inhibitor of the associated enzyme B-Raf, which plays a role in the regulation of cell growth. Dabrafenib has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma..

TAFINLAR® (dabrafenib) capsules, for oral use Initial U.S. Approval: 2013

Generic Name: dabrafenib

Tafinlar (dabrafenib)

TAFINLAR (dabrafenib) capsules, for oral use is available.

Get In Touch

TAFINLAR (dabrafenib) capsules suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand TAFINLAR (dabrafenib) capsules on prescription and Import License in Patient's Name only.

For overseas patients, TAFINLAR (dabrafenib) capsules can be made available in Send your enquiry to find TAFINLAR (dabrafenib) capsules in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for TAFINLAR (dabrafenib).

For TAFINLAR (dabrafenib) capsules Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Dabrafenib, Trametinib Combination Shows Response and Duration in BRAF V600E Mutated Tumors For More Details

Melanoma Patients See Magnified Benefit From Targeted Treatment Combo in Five-Year Outcomes Data For More Details

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Office in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jodhpur